Home > Animal Health & Nutrition > Veterinary Rabies Vaccines Market > Table of Contents

Veterinary Rabies Vaccines Market - By Animal Type (Companion [Dog, Cat], Livestock [Cattle, Sheep & Goat]), Application (Pre, Post- exposure Prophylaxis), Route of Administration (Oral, Injectable), End-use, Global Forecast (2024 – 2032)

  • Report ID: GMI10816
  • Published Date: Aug 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Rising incidence of rabies

3.2.1.2    Rising pet ownership globally

3.2.1.3    Favorable government regulations and policies

3.2.1.4    Increased awareness about rabies and its prevention

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost of rabies vaccines

3.2.2.2    Lack of awareness

3.3    Growth potential analysis

3.4    Regulatory landscape

3.5    Pipeline analysis

3.6    Porter's analysis

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Animal Type, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Companion animals

5.2.1    Dogs

5.2.2    Cats

5.2.3    Other companion animals

5.3    Livestock animals

5.3.1    Cattle

5.3.2    Sheep & goats

5.3.3    Other livestock animals

5.4    Wildlife

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Pre exposure prophylaxis

6.3    Post exposure prophylaxis

Chapter 7   Market Estimates and Forecast, By Route of Administration, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Oral

7.3    Injectable

Chapter 8   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Veterinary hospitals & clinics

8.3    Animal shelters & rescue organizations

8.4    Research institutes

Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Netherlands

9.3.7    Rest of Europe

9.4    Asia Pacific

9.4.1    Japan

9.4.2    China

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Rest of Latin America

9.6    Middle East and Africa

9.6.1    Saudi Arabia

9.6.2    South Africa

9.6.3    UAE

9.6.4    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    Biogénesis Bago S.A.

10.2    Bioveta, a.s.

10.3    Boehringer Ingelheim International GmbH

10.4    Ceva Santé Animale S.A.

10.5    Dyntec

10.6    Elanco Animal Health Incorporated

10.7    Indian Immunologicals Limited

10.8    Merck & Co., Inc.

10.9    Vaxxinova International B.V.

10.10    Virbac S.A.

10.11    Zoetis Inc.

  

Authors: Mariam Faizullabhoyg, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 378
  • Countries covered: 22
  • Pages: 219
 Download Free Sample